B+
Bull case
20%
Probability
Target price
$0.25
Analysis reference price unavailable
Analysis 2026-10-21 · RankAlpha Sentiment Codex
RKDA
Arcadia BiosciencesDNasdaq / Food Beverage & Tobacco
Last Price
Quote time unavailable
Current thesis
Reported July Zola sales, corrected inventory and shipping issues, and customer commitments for the planned espresso launch could precede a revenue recovery. Q2 operating cash use was $319,000 and quarter-end cash was $4.2 million [#SEC-8K-2026-08-13].
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-05.
What can break
Approved potential issuance and a discretionary reverse split create capital-structure uncertainty; neither approval proves execution [#8-K-2026-09-15].
Momentum
99
Value
54
Sentiment
34
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.13 · Bull $0.25 · Bear $0.06Analysis 2026-10-21; returns require an exact persisted reference.
Earnings
2026-11-05
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-30 • Vendor: Data Vendor v1
Scores
As of 2026-10-29 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-21 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-29
Investment thesis
As of 2026-10-29
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-29. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $12.00
Why
Momentum99 · Δ7d -
Value54 · Δ7d -0.0
Sentiment34 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-05.
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Approved potential issuance and a discretionary reverse split create capital-structure uncertainty; neither approval proves execution [#8-K-2026-09-15].
- • Large net losses and limited demonstrated profitability leave financing needs and dilution material [#SEC-8K-2026-08-13].
- • Q2 revenue remained slightly lower year over year, the common-stockholder net loss was $6.3 million, and recovery depends on unproven sustained demand.
Catalyst clock
2026-11-05
Planned Q4 Zola espresso launch
Lead driver: Value · See fundamentals
Momentum
99
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
54
47% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.0
Sentiment
34
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 98.5 / Value 54.5 / Sentiment 34.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-21. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.13
Analysis reference price unavailable
Analysis 2026-10-21 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.06
Analysis reference price unavailable
Analysis 2026-10-21 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-30
Fundamentals (TTM)
As of 2026-10-30
Market Cap
$380K
Beta
0.59
Shares Out
2.41M
P/E (TTM) · Derived
-0.1
P/S (TTM)
0.58
P/FCF (TTM) · Derived
-0.11
Rev YoY
-0.8%
EPS YoY
-35.8%
Gross Margin
+34.6%
Op Margin
-85.5%
Net Debt
-$4.56M
Current Ratio
3.49
As of 2026-10-29 • Updated nightlySource: Internal modelMethods & Data